SCIESCOPUSQ2
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
ELSEVIER TAIWAN, United Kingdom
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION is an academic journal published by ELSEVIER TAIWAN (United Kingdom). Identifiers: ISSN 1684-1182, eISSN 1995-9133. Indexed in SCIE, SCOPUS. Metrics: JIF 3.7, CiteScore 10.1, SJR 1.009, SNIP 1.13. Subject areas: IMMUNOLOGY, INFECTIOUS DISEASES, MICROBIOLOGY. tlooto lists 1,020 papers from this journal.
CiteScore
10.10
Scopus citation metric
SJR
1.009
SCImago rank
SNIP
1.13
Source normalized impact
Percentage rank
-
JIF percentile rank
Journal profile
- ISSN
- 1684-1182
- eISSN
- 1995-9133
- Abbreviation
- J MICROBIOL IMMUNOL
- Publisher
- ELSEVIER TAIWAN
- Country
- United Kingdom
Web of Science categories
SCIEIMMUNOLOGY, INFECTIOUS DISEASES, MICROBIOLOGY
Scopus ASJC categories
2400 General Immunology and Microbiology2723 Immunology and Allergy2725 Infectious Diseases2726 Microbiology (medical)
Keywords
Immunology | Infectious Diseases | Microbiology
Papers in this journal
Recent papers
- Comparative analysis of clinical outcomes and short-term treatment response of sputum microbiome between eosinophilic and non-eosinophilic COPD acute exacerbation.
2026
- Marked vacuolated neutrophils in Escherichia coli bacteremia.
2026
- Breakthrough invasive fusariosis under posaconazole prophylaxis in a neutropenic lymphoma patient.
2026
- Discriminating ST3 and non-ST3 Staphylococcus lugdunensis using MALDI-TOF and machine learning analysis.
2026
- Diffuse alveolar hemorrhage in systemic lupus erythematosus during the COVID-19 era-a retrospective analysis with mechanistic investigation.
2026
Most cited papers
- Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Facts and myths
2020 · 855 citations
- A systematic review of asymptomatic infections with COVID-19
2020 · 833 citations
- Genotype and phenotype of COVID-19: Their roles in pathogenesis
2020 · 806 citations
- TH17 responses in cytokine storm of COVID-19: An emerging target of JAK2 inhibitor Fedratinib
2020 · 711 citations
- Are children less susceptible to COVID-19?
2020 · 607 citations